spacer
home > pmps > spring 2007 > making it or faking it
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Making It or Faking It

Philippa Bruce of PRISYMID identifies the advantages of using holographic images in helping to combat the counterfeit of high value drugs, protecting brand identity and consumer safety

With counterfeits costing manufacturers billions of pounds per year, there is a growing need for sophisticated and cost-effective solutions. Counterfeiting has long been a problem for the luxury goods market, automotive parts, apparel industry and banking sector. In the pharmaceutical industry, however, the risk of counterfeit drugs entering the supply chain poses a serious health hazard to consumers as well as a substantial financial cost to manufacturers.

In fact, the World Health Organization estimates that as much as $35 billion of pharmaceuticals sold globally each year are fakes. Due to its very nature, counterfeiting in the industry is difficult to quantify – the true extent is unknown, but the real figure is likely to be higher still. What is clear, however, is that the problem is on the rise.

It is now widely acknowledged that counterfeit drugs are no longer confined to ‘black’ markets in specific countries but are infiltrating legitimate channels globally. The emergence and popularity of the internet has compounded the problem, enabling counterfeiters to reach consumers more easily with their cut-price drugs. Greater access to scanning and imaging technology, used by counterfeiters to reproduce pharmaceutical packaging, is another possible factor contributing to this rise.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Philippa Bruce is Sales Manager for PRISYMID – a global leader in labelling, RFID and barcode solutions. The team has over 20 years’ experience in delivering high quality labelling and auto-identification solutions to the life sciences industry. With offices in the UK, Germany and the US, as well as a network of international partners worldwide, the company is developing new and innovative products aimed at the global life sciences sector, particularly focusing on anti-counterfeiting solutions and FDA regulations. Philippa has 15 years’ experience in the labelling industry and, prior to working at PRISYMID, was Business Manager for Worldmark.
spacer
Philippa Bruce
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Preparation of Pharmaceutical Samples for Metals Analysis

RSSL

There has been a lot of discussion regarding the methods of analysis for pharmaceutical products as we await the upcoming changes to both the EP and USP, relating to the analysis of metal impurities.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement